Alimetrix provides Relevant Diagnostics Empowering Actionable Therapy® Alimetrix is a CLIA and CAP accredited molecular diagnostic company whose mission is to alleviate patient suffering through the development of state of the art diagnostic tools. Utilizing unique disease insight, coupled with proprietary technologies, Alimetrix is able to provide exceptionally accurate, actionable test results in a timely manner. Being armed with finely detailed and accurate information allows clinicians to gain a clear understanding of the therapeutic needs of the patient. As part of our clinician partnership we seek to provide bestin-class diagnostic assays, helping to facilitate better patient outcomes and actively reduce patient suffering.

Joel Peek, PhD
CEO, President, Founder

Mark McQuain, MS, PhD
Chief Technical Officer

Carol Quinter, MSC, PhD
Laboratory Director of Clinical Services

Richard Spera, MD, FACP
Medical Director

Samantha Bond, MS
Director of Microbiology

Jonas Boateng, PhD
Director of Next-Generation Sequencing

All resident associate companies on the HudsonAlpha campus are independently owned and operated.